Skip to main content

Carbamazepine

NDC 51407-895 · Golden State Medical Supply, Inc.

Generic nameCarbamazepine
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength100 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryANDA

Packages

51407-895-01 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-895-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-0384 — Carbamazepine, 50090-5740 — Carbamazepine, 50268-160 — CARBAMAZEPINE, 50268-170 — Carbamazepine, 50268-171 — Carbamazepine, 50268-172 — Carbamazepine, 50742-257 — carbamazepine, 50742-258 — carbamazepine, 50742-259 — carbamazepine, 51407-215 — Carbamazepine, 51407-896 — Carbamazepine, 51407-897 — Carbamazepine, 51672-4005 — Carbamazepine, 51672-4041 — Carbamazepine, 51672-4047 — Carbamazepine, 51672-4050 — Carbamazepine, 51672-4123 — Carbamazepine, 51672-4124 — Carbamazepine, 51672-4125 — Carbamazepine, 54092-171 — carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.